Multiple Myeloma Treatment Strategies with Novel Agents in 2011: A European Perspective

The arrival of the novel agents thalidomide, bortezomib, and lenalidomide has significantly changed our approach to the management of multiple myeloma and, importantly, patient outcomes have improved. These agents have been investigated intensively in different treatment settings, providing us with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ludwig, Heinz, Beksac, Meral, Bladé, Joan, Cavenagh, Jamie, Cavo, Michele, Delforge, Michel, Dimopoulos, Meletios, Drach, Johannes, Einsele, Hermann, Facon, Thierry, Goldschmidt, Hartmut, Harousseau, Jean-Luc, Hess, Urs, Kropff, Martin, Leal da Costa, Fernando, Louw, Vernon, Magen-Nativ, Hila, Mendeleeva, Larisa, Nahi, Hareth, Plesner, Torben, San-Miguel, Jesús, Sonneveld, Pieter, Udvardy, Miklos, Sondergeld, Pia, Palumbo, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2011
Assuntos:
Academia-Pharma Intersect
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228121/
https://ncbi.nlm.nih.gov/pubmed/21441574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0386
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados